Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Molecular Epidemiology and Evolutionary Trajectory of Emerging Echovirus 30, Europe

  • Benschop, Kimberley SM
  • Broberg, Eeva K
  • Hodcroft, Emma
  • Schmitz, Dennis
  • Albert, Jan
  • Baicus, Anda
  • Bailly, Jean-Luc
  • Baldvinsdottir, Gudrun
  • Berginc, Natasa
  • Blomqvist, Soile
  • Böttcher, Sindy
  • Brytting, Mia
  • Bujaki, Erika
  • Cabrerizo, Maria
  • Celma, Cristina
  • Cinek, Ondrej
  • Claas, Eric C J
  • Cremer, Jeroen
  • Dean, Jonathan
  • Dembinski, Jennifer L
  • Demchyshyna, Iryna
  • Diedrich, Sabine
  • Dudman, Susanne
  • Dunning, Jake
  • Dyrdak, Robert
  • Emmanouil, Mary
  • Farkas, Agnes
  • De Gascun, Cillian
  • Fournier, Guillaume
  • Georgieva, Irina
  • Gonzalez-Sanz, Ruben
  • van Hooydonk-Elving, Jolanda
  • Jääskeläinen, Anne J
  • Jancauskaite, Ruta
  • Keeren, Kathrin
  • Fischer, Thea K
  • Krokstad, Sidsel
  • Nikolaeva-Glomb, Lubomira
  • Novakova, Ludmila
  • Midgley, Sofie Elisabeth
  • Mirand, Audrey
  • Molenkamp, Richard
  • Morley, Ursula
  • Mossong, Joël
  • Muralyte, Svajune
  • Murk, Jean-Luc
  • Nguyen, Trung
  • Nordbø, Svein A
  • Österback, Riikka
  • Pas, Suzan
  • Pellegrinelli, Laura
  • Pogka, Vassiliki
  • Prochazka, Birgit
  • Rainetova, Petra
  • Van Ranst, Marc
  • Roorda, Lieuwe
  • Schuffenecker, Isabelle
  • Schuurman, Rob
  • Stoyanova, Asya
  • Templeton, Kate
  • Verweij, Jaco J
  • Voulgari-Kokota, Androniki
  • Vuorinen, Tytti
  • Wollants, Elke
  • Wolthers, Katja C
  • Zakikhany, Katherina
  • Neher, Richard
  • Harvala, Heli
  • Simmonds, Peter
In 2018, an upsurge in echovirus 30 (E30) infections was reported in Europe. We conducted a large-scale epidemiologic and evolutionary study of 1,329 E30 strains collected in 22 countries in Europe during 2016-2018. Most E30 cases affected persons 0-4 years of age (29%) and 25-34 years of age (27%). Sequences were divided into 6 genetic clades (G1-G6). Most (53%) sequences belonged to G1, followed by G6 (23%), G2 (17%), G4 (4%), G3 (0.3%), and G5 (0.2%). Each clade encompassed unique individual recombinant forms; G1 and G4 displayed >2 unique recombinant forms. Rapid turnover of new clades and recombinant forms occurred over time. Clades G1 and G6 dominated in 2018, suggesting the E30 upsurge was caused by emergence of 2 distinct clades circulating in Europe. Investigation into the mechanisms behind the rapid turnover of E30 is crucial for clarifying the epidemiology and evolution of these enterovirus infections.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development of a multiplex assay for antibody detection in serum against pathogens affecting ruminants

  • Hoste, Alexis C.R.
  • Ruiz, Tamara
  • Fernández-Pacheco, Paloma
  • Jiménez-Clavero, Miguel Ángel
  • Djadjovski, Igor
  • Moreno, Sandra
  • Brun Torres, Alejandro
  • Edwards, Thomas A.
  • Barr, John N.
  • Rueda, Paloma
  • Sastre, Patricia
11 Pág. Centro de Investigación en Sanidad Animal (CISA), Numerous infectious diseases impacting livestock impose an important economic burden and in some cases also represent a threat to humans and are classified as zoonoses. Some zoonotic diseases are transmitted by vectors and, due to complex environmental and socio-economic factors, the distribution of many of these pathogens is changing, with increasing numbers being found in previously unaffected countries. Here, we developed a multiplex assay, based on a suspension microarray, able to detect specific antibodies to five important pathogens of livestock (three of them zoonotic) that are currently emerging in new geographical locations: Rift Valley fever virus (RVFV), Crimean-Congo haemorrhagic fever virus (CCHFV), Schmallenberg virus (SBV), Bluetongue virus (BTV) and the bacteria complex Mycobacterium tuberculosis. Using the Luminex platform, polystyrene microspheres were coated with recombinant proteins from each of the five pathogens. The mix of microspheres was used for the simultaneous detection of antibodies against the five corresponding diseases affecting ruminants. The following panel of sera was included in the study: 50 sera from sheep experimentally infected with RVFV, 74 sera from calves and lambs vaccinated with SBV, 26 sera from cattle vaccinated with Mycobacterium bovis, 30 field sera from different species of ruminants infected with CCHFV and 88 calf sera infected with BTV. Finally, to determine its diagnostic specificity 220 field sera from Spanish farms free of the five diseases were assessed. All the sera were classified using commercial ELISAs specific for each disease, used in this study as the reference technique. The results showed the multiplex assay exhibited good performance characteristics with values of sensitivity ranging from 93% to 100% and of specificity ranging from 96% to 99% depending on the pathogen. This new tool allows the simultaneous detection of antibodies against five important pathogens, reducing the volume of sample needed and the time of analysis where these pathogens are usually tested individually., We would like to thank the EU Marie Skłodowska-Curie Actions (MSCA) Innovative Training Network (ITN): H2020-(MSCA)ITN-2016, under grant No 721367 (to Alexis C. R. Ho), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Multiplex Assay for Simultaneous Detection of Antibodies against Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein and Glycoproteins in Ruminants

  • Hoste, Alexis C.R.
  • Djadjovski, Igor
  • Jiménez-Clavero, Miguel Ángel
  • Rueda, Paloma
  • Barr, John N.
  • Sastre, Patricia
10 Pág., Crimean-Congo hemorrhagic fever virus (CCHFV) is a widespread tick-borne zoonotic virus that causes Crimean-Congo hemorrhagic fever (CCHF). CCHF is asymptomatic in infected animals but can develop into severe illness in humans, with high case-fatality rates. Due to complex environmental and socio-economic factors, the distribution of CCHFV vectors is changing, leading to disease occurrence in previously unaffected countries. Neither an effective treatment nor a vaccine has been developed against CCHFV; thus, surveillance programs are essential to limit and control the spread of the virus. Furthermore, the WHO highlighted the need of assays that can cover a range of CCHFV antigenic targets, DIVA (differentiating infected from vaccinated animals) assays, or assays for future vaccine evaluation. Here, we developed a multiplex assay, based on a suspension microarray, able to detect specific antibodies in ruminants to three recombinantly produced CCHFV proteins: the nucleocapsid (N) protein and two glycoproteins, GN ectodomain (GNe), and GP38. This triplex assay was used to assess the antibody response in naturally infected animals. Out of the 29 positive field sera to the N protein, 40% showed antibodies against GNe or GP38, with 11 out of these 12 samples being positive to both glycoproteins. To determine the diagnostic specificity of the test, a total of 147 sera from Spanish farms free of CCHFV were included in the study. This multiplex assay could be useful to detect antibodies to different proteins of CCHFV as vaccine target candidates and to study the immune response to CCHFV in infected animals and for surveillance programs to prevent the further spread of the virus. IMPORTANCE Crimean-Congo hemorrhagic fever virus (CCHFV) causes Crimean-Congo hemorrhagic fever, which is one of the most important tick-borne viral diseases of humans and has recently been found in previously unaffected countries such as Spain. The disease is asymptomatic in infected animals but can develop into severe illness in humans. As neither an effective treatment nor a vaccine has been developed against CCHFV, surveillance programs are essential to limit and control the spread of the virus. In this study, a multiplex assay detecting antibodies against different CCHFV antigens in a single sample and independent of the ruminant species has been developed. This assay could be very useful in surveillance studies, to control the spread of CCHFV and prevent future outbreaks, and to better understand the immune response induced by CCHFV., We thank the EU Marie Skłodowska-Curie Actions (MSCA) Innovative Training Network (ITN): H2020-MSCA-ITN-2016, under grant no. 721367 (to Alexis C. R. Hoste) and the MediLabSecure Project, supported by the European Commission (DEVCO: IFS/2018/402-247) (to Igor Djadjovski and Miguel Ángel Jiménez-Clavero)., Peer reviewed